JPRN-UMIN000026658未知未知
64Cu-DOTA-nivolumab PET imaging in patients with malignant melanoma or non-small cell lung cancer. - Nivolumab PET imaging
ational Cancer Center Hospital, Tokyo, Japan0 个研究点目标入组 50 人开始时间: 2017年3月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Previous any drug allergies. 2. Uncontrolled any comorbidities (eg; cardiovascular disease, diabetes and psychiatric disease) 3. Active systemic infectious disease 4. Previous history of interstitial lung disease or pulmonary fibrosis disease. 5. Pregnant or lactating women. 6. Patients who recognized inappropriate candidate by physician.
研究者
相似试验
招募中
不适用
tility study of PET imaging with 64Cu-DOTA labeled antibody probes against HER2 and EGFRBreast cancer, Gastric cancer, Colorectal cancer, GliomaJPRN-UMIN000017446ational Cancer Center Hospital200
进行中（未招募）
1 期
Combined 64Cu-DOTATATE and 18F-FDG PET/CT Imaging in Patients with Neuroendocrine Tumorseuroendocrine neoplasmsMedDRA version: 21.0Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10057270Term: Neuroendocrine carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10068916Term: Pancreatic neuroendocrine tumor metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10071542Term: Neuroendocrine carcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10077560Term: Gastroenteropancreatic neuroendocrine tumor diseaseSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10067518Term: Pancreatic neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085846Term: Duodenal neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085958Term: Small intestine neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-005919-30-DKDepartment of Clinical Physiology and Nuclear Medicine, Rigshospitalet200
进行中（未招募）
1 期
64Cu-DOTATATE PET/CT-skanning to diagnose infection in the heart valvesInfective endocarditisEUCTR2021-005501-27-DKRigshospitalet65
招募中
不适用
Feasibility study of PET Imaging with 64Cu-DOTA-trastuzumab in HER2 positive breast cancer1. Patients with invasive ductal carcinoma of breast. 2. HER2 positive (IHC 3+>or FISH positive) breast cancer 3. Currently taking or about to commence treatment with trastuzumab or trastumab based chemotherapy 4. Age: >20 years, <75 years 5. ECOG Performance Score 0 or 1. 6. Good main organ function 7. Capability to be received PET scan. 8. Signed informed consentJPRN-UMIN000004170ational Cancer Center Hospital40
进行中（未招募）
1 期
Octreotide PET/CT scan for the imaging of disease activity in neurologic and cardiac sarcoidosis.Sarcoidosis.EUCTR2016-002160-14-NLSt. Antonius Hospital